Market Size of EPA And DHA Industry
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 1.92 Billion |
| Market Size (2029) | USD 2.76 Billion |
| CAGR (2024 - 2029) | 7.51 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | Asia-Pacific |
Major Players.webp "EPA And DHA Market Major Players"){kind=logo}
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
EPA & DHA Market Analysis
The EPA And DHA Market size is estimated at USD 1.92 billion in 2024, and is expected to reach USD 2.76 billion by 2029, growing at a CAGR of 7.51% during the forecast period (2024-2029).
The market for EPA and DHA is primarily driven by increasing awareness regarding potential health benefits associated with fatty acids. Furthermore, the rising incidences of chronic conditions, such as high blood pressure, diabetes, and cardiovascular disease, augment the demand for EPA and DHA ingredients. These algae omega-3 ingredients help improve heart health by lowering triglycerides, raising good cholesterol levels, and protecting the heart from irregular heart rhythms. They also support muscle recovery, reduce the risk of certain cancers, and aid normal brain and eye development in babies. Moreover, health organizations and regulatory bodies worldwide, such as the Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA), recognize the health benefits of EPA and DHA and provide dietary recommendations and guidelines to promote their consumption. Such regulatory support contributes to the growth of the EPA and DHA market by fostering consumer confidence and awareness. Besides this, key companies focus on mergers and acquisitions, expanding their product portfolio, and launching new products to maintain their position in the market. For instance, in February 2024, Epax launched a full-spectrum oil with a combination of omega 3, 9, and 11, which has particular potential for skin health supplements.
EPA & DHA Industry Segmentation
EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are long-chain omega-3 fatty acids from various vegetable and animal sources.
The global EPA and DHA market study is segmented by type, source, application, and geography. By type, the market studied is segmented into eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Based on the source, the market studied is segmented into fish oil, algae oil, krill oil, and other sources. By application, the study covers infant formulae, dietary supplements, fortified food and beverages, pharmaceuticals, and other applications. Furthermore, the report takes into consideration the market in established and emerging economies of North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. For each segment, the market sizing and forecasts have been done on the basis of value (in USD).
| Type | |
| Eicosapentaenoic Acid (EPA) | |
| Docosahexaenoic Acid (DHA) |
| Source | |
| Fish Oil | |
| Algae Oil | |
| Krill Oil | |
| Other Sources |
| Application | |
| Infant Formulae | |
| Dietary Supplements | |
| Fortified Food and Beverages | |
| Pharmaceuticals | |
| Other Applications |
| Geography | |||||||||
| |||||||||
| |||||||||
| |||||||||
| |||||||||
|
EPA And DHA Market Size Summary
The EPA and DHA market is experiencing significant growth, driven by increasing consumer awareness of the health benefits associated with these omega-3 fatty acids. The demand for EPA and DHA is bolstered by the rising prevalence of chronic health conditions such as cardiovascular diseases, diabetes, and high blood pressure, which these fatty acids help mitigate. Regulatory bodies like the FDA and EFSA support the consumption of EPA and DHA through dietary recommendations, enhancing consumer confidence and market expansion. Key industry players are actively engaging in mergers, acquisitions, and product innovations to strengthen their market presence. For example, Epax's recent launch of a full-spectrum oil highlights the industry's focus on expanding product offerings to cater to diverse health needs.
The market is characterized by a growing consumer preference for DHA-infused food and supplements, reflecting a shift towards nutritionally enriched products that offer comprehensive health benefits. This trend is particularly evident in the Asia-Pacific region, where countries like China and Japan lead in omega-3 consumption, primarily from fish-based sources. The demand for omega supplements is also rising among children, driven by parental awareness of the importance of EPA and DHA in brain development. The global market is fragmented, with major players such as Corbion NV, KD Pharma Group, and Neptune Wellness Solutions competing through strategic partnerships and product innovations to capture a larger market share. Recent collaborations, like DSM-Firmenich's partnership with SCN BestCo to launch omega-3 gummies, exemplify the industry's commitment to expanding its product portfolio and meeting evolving consumer demands.
EPA And DHA Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Drivers
-
1.1.1 Increasing Awareness Of Health Benefits Associated With EPA And DHA
-
1.1.2 Demand for Concentrated Forms of Omega 3
-
-
1.2 Market Restraints
-
1.2.1 High Market Price And Downstream Processing Cost Of Algae-Based Ingredients
-
-
1.3 Porter's Five Forces Analysis
-
1.3.1 Bargaining Power of Suppliers
-
1.3.2 Bargaining Power of Buyers
-
1.3.3 Threat of New Entrants
-
1.3.4 Threat of Substitute Products
-
1.3.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 Type
-
2.1.1 Eicosapentaenoic Acid (EPA)
-
2.1.2 Docosahexaenoic Acid (DHA)
-
-
2.2 Source
-
2.2.1 Fish Oil
-
2.2.2 Algae Oil
-
2.2.3 Krill Oil
-
2.2.4 Other Sources
-
-
2.3 Application
-
2.3.1 Infant Formulae
-
2.3.2 Dietary Supplements
-
2.3.3 Fortified Food and Beverages
-
2.3.4 Pharmaceuticals
-
2.3.5 Other Applications
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Mexico
-
2.4.1.3 Canada
-
2.4.1.4 Rest of North America
-
-
2.4.2 Europe
-
2.4.2.1 Spain
-
2.4.2.2 United Kingdom
-
2.4.2.3 Germany
-
2.4.2.4 France
-
2.4.2.5 Russia
-
2.4.2.6 Italy
-
2.4.2.7 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 Rest of Asia-Pacific
-
-
2.4.4 South America
-
2.4.4.1 Brazil
-
2.4.4.2 Argentina
-
2.4.4.3 Rest of South America
-
-
2.4.5 Middle East and Africa
-
2.4.5.1 United Arab Emirates
-
2.4.5.2 South Africa
-
2.4.5.3 Rest of Middle East and Africa
-
-
-
EPA And DHA Market Size FAQs
How big is the EPA And DHA Market?
The EPA And DHA Market size is expected to reach USD 1.92 billion in 2024 and grow at a CAGR of 7.51% to reach USD 2.76 billion by 2029.
What is the current EPA And DHA Market size?
In 2024, the EPA And DHA Market size is expected to reach USD 1.92 billion.
